• Corpus ID: 37618938

Acid CleavageLDeprotection in Fmoc / tBu Solid-Phase Peptide Synthesis

@inproceedings{Dick2003AcidCI,
  title={Acid CleavageLDeprotection in Fmoc / tBu Solid-Phase Peptide Synthesis},
  author={Fritz Dick},
  year={2003}
}
In general, a solid-phase peptide synthesis (SPPS) consists of the assembly of a protected peptide chain on a polymeric support (=synthetic step) and the subsequent cleavage/deprotection to release the crude, deprotected peptide from the solid support (=cleavage step). Usually, these two steps are followed by chromatographic purification of the crude peptide (see Chapters 1,2,4, and 5, PAP). The techniques to synthesize protected peptides or peptide fragments are discussed in Chapter 14. This… 

Figures and Tables from this paper

References

SHOWING 1-10 OF 13 REFERENCES

Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids.

  • G. FieldsR. Noble
  • Chemistry, Biology
    International journal of peptide and protein research
  • 1990
The great variety of conditions under which Fmoc solid phase peptide synthesis may be carried out represents a truly "orthogonal" scheme, and thus offers many unique opportunities for bioorganic chemistry.

A mild procedure for solid phase peptide synthesis: use of fluorenylmethoxycarbonylamino-acids

Use of base-labile N-fluorenylmethoxycarbonylamino-acids, t-butyl based side chain protecting groups, and a p-alkoxybenzyl ester resin linkage provides a simple, rapid, and exceptionally mild

Isolation, amino acid sequence, and synthesis of dermaseptin, a novel antimicrobial peptide of amphibian skin.

The synthetic replicate was shown to be indistinguishable from natural dermaseptin with respect to chromatographic properties, amino acid sequence determination, and mass spectrometry analysis.

Isolation and Structure of the Sex Pheromone Inhibitor , iPD 1 , Excreted by Streptococcus faecalis Donor Strains Harboring Plasmid pPD 1

The isolation, structure elucidation, and total synthesis of another sex pheromone inhibitor, iPD1, which is produced by pPD1-harboring donor strains and inhibits cPD1 activity is reported.

Cyclic melanotropins. 9. 7-D-Phenylalanine analogues of the active-site sequence.

The 4-12 and 4-13 cyclic D-Phe7 analogues displayed the phenomenon of superagonism, which is a time-dependent increase in efficacy over that produced by an equipotent concentration of the native hormone.